GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dannex Ayrton Starwin PLC (XGHA:DASPHARMA) » Definitions » Research & Development

Dannex Ayrton Starwin (XGHA:DASPHARMA) Research & Development : GHS Mil (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Dannex Ayrton Starwin Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Dannex Ayrton Starwin's Research & Development for the six months ended in . 20 was GHS0.00 Mil. Dannex Ayrton Starwin does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.


Dannex Ayrton Starwin Research & Development Historical Data

The historical data trend for Dannex Ayrton Starwin's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dannex Ayrton Starwin Research & Development Chart

Dannex Ayrton Starwin Annual Data
Trend
Research & Development

Dannex Ayrton Starwin Semi-Annual Data
Research & Development

Dannex Ayrton Starwin Research & Development Calculation

This is the expense the company spent on research and development.


Dannex Ayrton Starwin  (XGHA:DASPHARMA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Dannex Ayrton Starwin Research & Development Related Terms

Thank you for viewing the detailed overview of Dannex Ayrton Starwin's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Dannex Ayrton Starwin (XGHA:DASPHARMA) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.

Dannex Ayrton Starwin (XGHA:DASPHARMA) Headlines

No Headlines